Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_84d9adaa7e7ce01ce8020f5c721aba10 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-191 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-517 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55 |
filingDate |
2008-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9af8c6fb993453fd6027990ea66fd133 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_198097344c5196905500b643ee23c710 |
publicationDate |
2009-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2009203671-A1 |
titleOfInvention |
Method of treating cancer |
abstract |
Methods of treating cancer in patients comprising administering thereto aurora kinase inhibitors and TRAIL (tumor necrosis factor (TNF)-related apoptosis inducing ligand) inhibitors is disclosed. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10736932-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11299528-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11027047-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11007251-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11084879-B2 |
priorityDate |
2007-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |